Matches in Wikidata for { <http://www.wikidata.org/entity/Q63819439> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q63819439 description "clinical trial" @default.
- Q63819439 description "ensayu clínicu" @default.
- Q63819439 description "klinisch onderzoek" @default.
- Q63819439 description "клінічне випробування" @default.
- Q63819439 description "կլինիկական փորձարկում" @default.
- Q63819439 name "A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relap" @default.
- Q63819439 type Item @default.
- Q63819439 label "A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relap" @default.
- Q63819439 prefLabel "A Study of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relap" @default.
- Q63819439 P1050 Q63819439-1FEEE50B-160C-4322-BC14-33D21286D70C @default.
- Q63819439 P1050 Q63819439-59A61AA6-8C08-4F19-92CE-8C519396994B @default.
- Q63819439 P1132 Q63819439-226D0671-A29D-45B6-8106-54B8FC82C10E @default.
- Q63819439 P1476 Q63819439-220BC87C-0879-4B70-A562-22F9C2EF9B82 @default.
- Q63819439 P2899 Q63819439-DF56B7E7-5134-4D53-BE7F-993530636592 @default.
- Q63819439 P3098 Q63819439-C57C3EFC-230A-422B-ADA1-80BB09D5430C @default.
- Q63819439 P31 Q63819439-AB38BA91-5473-4C2B-8550-204431AABF38 @default.
- Q63819439 P4844 Q63819439-6CD91894-5AEF-427E-951E-D554DFB3FAB0 @default.
- Q63819439 P580 Q63819439-F74B8B1E-29A1-4813-A40C-0F61EB6A283B @default.
- Q63819439 P582 Q63819439-4D2F6F29-DDC6-448D-BB10-1CCB2D82163F @default.
- Q63819439 P6099 Q63819439-C8EE82AA-157B-4762-AF58-FCA6B21E96F4 @default.
- Q63819439 P8363 Q63819439-153BBDB6-F2F6-47CD-8330-62DC4ED3BD83 @default.
- Q63819439 P1050 Q208414 @default.
- Q63819439 P1050 Q29496 @default.
- Q63819439 P1132 "+91" @default.
- Q63819439 P1476 "An Open-Label, Multicenter, Phase I Trial of the Safety and Pharmacokinetics of Escalating Doses of DCDT2980S in Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia And DCDT2980S in Combination With Rituximab in Patients With Relapsed or Refractory B-Cell Non Hodgkin's Lymphoma" @default.
- Q63819439 P2899 "+18" @default.
- Q63819439 P3098 "NCT01209130" @default.
- Q63819439 P31 Q30612 @default.
- Q63819439 P4844 Q412323 @default.
- Q63819439 P580 "2010-10-01T00:00:00Z" @default.
- Q63819439 P582 "2015-03-01T00:00:00Z" @default.
- Q63819439 P6099 Q5452194 @default.
- Q63819439 P8363 Q78089383 @default.